| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |